Enovis Corporation (ENOV)
Market Cap | 3.29B |
Revenue (ttm) | 1.71B |
Net Income (ttm) | -33.26M |
Shares Out | 54.62M |
EPS (ttm) | -0.61 |
PE Ratio | n/a |
Forward PE | 23.69 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 317,773 |
Open | 61.05 |
Previous Close | 60.28 |
Day's Range | 60.74 - 62.50 |
52-Week Range | 43.04 - 66.14 |
Beta | 2.06 |
Analysts | Strong Buy |
Price Target | 74.88 (+19.89%) |
Earnings Date | May 2, 2024 |
About ENOV
Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments. Its Prevention and Recovery segment offers orthopedic solutions and recovery sciences including rigid and soft orthopedic bracing, hot and cold therapy, bone growth stimulators, vascular th... [Read more]
Financial Performance
In 2023, Enovis's revenue was $1.71 billion, an increase of 9.22% compared to the previous year's $1.56 billion. Losses were -$33.26 million, 150.2% more than in 2022.
Financial StatementsAnalyst Forecast
According to 9 analysts, the average rating for ENOV stock is "Strong Buy." The 12-month stock price forecast is $74.88, which is an increase of 19.89% from the latest price.
News
Enovis Announces Fourth Quarter and Full Year 2023 Results
Wilmington, DE, Feb. 22, 2024 (GLOBE NEWSWIRE) -- —Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology growth company, today announced its financial results for the fourth quarte...
Enovis™ to Highlight Latest Technologies Across the Orthopedic Care Continuum at 2024 AAOS Annual Meeting
WILMINGTON, DE, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology company, will showcase its latest technologies across the orthopedic care c...
Enovis to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024
Wilmington, DE, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that Brady Shirley, President and COO, Ben ...
Enovis to Host Fourth Quarter and Full Year 2023 Conference Call on February 22nd
Wilmington, DE, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will host an investor conference call and...
Enovis Introduces the DonJoy ROAM™ OA Knee Brace
The newest innovation in unloader braces is comfortable, easy to use and effective. The newest innovation in unloader braces is comfortable, easy to use and effective.
Enovis Completes Acquisition of LimaCorporate S.p.A
WILMINGTON, Del., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV, “Enovis” or the “Company”) an innovation-driven, medical technology growth company, today announced that it closed ...
Enovis to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
Wilmington, DE, Dec. 28, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will meet with inv...
Enovis Announces Business Segment Leadership Transition Plan
Wilmington, DE, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Enovis Corporation (NYSE: ENOV), an innovation-driven medical technology growth company, today announced that Brady R. Shirley, the Company's Preside...
Enovis to participate in the 6th Annual EverCore ISI HealthCONx Conference
Wilmington, DE, Nov. 16, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced that it will participate in the 6th Annual Everco...
Enovis Announces Third Quarter 2023 Results and Raises Full-Year Outlook
Wilmington, DE, Nov. 07, 2023 (GLOBE NEWSWIRE) -- —Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology growth company, today announced its financial results for the third quarter...
ENOVIS CORPORATION ANNOUNCES PRICING OF PRIVATE OFFERING OF $400 MILLION OF 3.875% CONVERTIBLE SENIOR NOTES DUE 2028
Wilmington, DE, Oct. 20, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV, “Enovis” or the “Company”) today announced the pricing of $400 million aggregate principal amount of 3.875% Convertib...
Enovis Corporation Releases Preliminary Information About Its Performance for the Third Quarter 2023
Wilmington, DE, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV, “Enovis” or the “Company”) today released the following preliminary information about its performance for the third q...
Enovis Corporation Announces Proposed Private Offering of $400 Million of Convertible Senior Notes
Wilmington, DE, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV, “Enovis” or the “Company”) today announced its intention to offer, subject to market conditions and other factors, $4...
Enovis to Host Third Quarter 2023 Results Conference Call on November 7th
Wilmington, DE, Oct. 16, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that it will host an investor conference ca...
Enovis to acquire implant maker LimaCorporate for 800 million euros in cash and stock
Medical technology company Enovis Corp. ENOV, -0.44% said Monday it has reached an agreement to acquire LimaCorporate S.p.A., a privately held orthopedic company that specializes in restoring motion u...
Enovis to Acquire LimaCorporate S.p.A.
Wilmington, DE, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV, “Enovis” or the “Company”), an innovation-driven, medical technology growth company, today announced a definitive ag...
Enovis to buy prosthetic implants maker LimaCorporate for $850 mln
Enovis Corp , a U.S. maker of orthopedic bracing and shoe inserts, said on Monday it had agreed to acquire Italian surgical implant manufacturer LimaCorporate for about 800 million euros ($850 million...
Enovis Debuts New Foot & Ankle Offerings at the AOFAS Annual Meeting
New solutions in Percutaneous and Open Bunion procedures, External Fixation, and Patient Specific Instrumentation, will be featured as part of the company's growing evidence based, high tech portfolio...
Enovis to Participate in Upcoming Investor Conferences
Wilmington, DE, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate i...
Enovis Announces Second Quarter 2023 Results and Raises Full-Year Outlook
Wilmington, DE, Aug. 03, 2023 (GLOBE NEWSWIRE) -- —Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology growth company, today announced its financial results for the second quarte...
Enovis to Host Second Quarter 2023 Results Conference Call on August 3rd
Wilmington, DE, July 11, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that it will host an investor conference ca...
Enovis™ Recognized as One of America's Greatest Workplaces 2023 by Newsweek
Wilmington, DE, July 06, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced today that it has been recognized as one of Ameri...
Enovis™ Completes Acquisition of Novastep®
Wilmington, DE, June 28, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that it closed the acquisition of Novastep...
Enovis to Participate in Investor Conferences in June
Wilmington, DE, June 02, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will participate i...
Enovis Announces First Quarter 2023 Results
Wilmington, DE, May 04, 2023 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven medical technology growth company, today announced its financial results for the first quarter e...